Imputing observed blood pressure for antihypertensive treatment: Impact on population and genetic analyses

American Journal of Hypertension

Volumn 27, Issue 6, 2014, Pages 828-837

  Rana, Brinda K ^a,b,c   Dhamija, Anish ^a   Panizzon, Matthew S ^a,b   Spoon, Kelly M ^a,b   Vasilopoulos, Terrie ^d   Franz, Carol E ^a,b   Grant, Michael D ^e   Jacobson, Kristen C ^d   Kim, Kathleen ^f   Lyons, Michael J ^e   McCaffery, Jeanne M ^g   Stein, Phyllis K ^h   Xian, Hong ⁱ   O'Connor, Daniel T ^b   Kremen, William S ^a,b,c,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e BOSTON UNIVERSITY   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^g BROWN UNIVERSITY   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ SAINT LOUIS UNIVERSITY   (United States)

Author keywords

antihypertensive; blood pressure; body mass index; heritability; hypertension; twins; VETSA

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; DIASTOLIC BLOOD PRESSURE; DIZYGOTIC TWINS; ETHNICITY; GENETIC ANALYSIS; GENETIC CORRELATION; GENETIC VARIABILITY; HERITABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; ALGORITHM; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; DIAGNOSIS; DRUG COMBINATION; DRUG EFFECTS; DRUG THERAPY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HEALTH SURVEY; HEREDITY; MIDDLE AGED; NONLINEAR SYSTEM; REGISTER; RISK ASSESSMENT; STATISTICAL MODEL; TREATMENT OUTCOME; TWINS; VIET NAM;

ALGORITHMS; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASES IN TWINS; DRUG THERAPY, COMBINATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NONLINEAR DYNAMICS; PHENOTYPE; POPULATION SURVEILLANCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VIETNAM;

EID: 84900872116     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt271     Document Type: Article

References (54)

1. Vinck WJ, Fagard RH, Loos R, Vlietinck R. The impact of genetic and environmental influences on blood pressure variance across age-groups. JHypertens 2001; 19:1007-1013.
2. Fagard RH, Loos RJ, Beunen G, Derom C, Vlietinck R. Influence of chorionicity on the heritability estimates of blood pressure: a study in twins. JHypertens 2003; 21:1313-1318.
3. Schunkert H, Hense HW, Döring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998; 32:510-513.
4. Brand E, Wang JG, Herrmann SM, Staessen JA. An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. JHypertens 2003; 21:729-737.
5. Küpper N, Willemsen G, Riese H, Posthuma D, Boomsma DI, de Geus EJ. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension 2005; 45:80-85.
6. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24:2911-2935.
7. Hunt SC, Ellison RC, Atwood LD, Pankow JS, Province MA, Leppert ME Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2002;40:1-6.
8. Cui J, Hopper JL, Harrap SB. Genes and family environment explain correlations between blood pressure and body mass index. Hypertension 2002;40:7-12.
9. Chen Y, Zhang K, Wen G, Rao F, Sanchez AP, Wang L, Rodriguez-Flores JL, Mahata M, Mahata SK, Waaien J, Ziegler MG, Hamilton BA, O'Connor DT Human dopamine beta-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure. Am JHypertens 2011; 24:24-32.
10. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, Aulchenko Y, Lumley T, Köttgen A, Vasan RS, Rivadeneira F, Eiriksdottir G, Guo X, Arking DE, Mitchell GF, Mattace-Raso FU, Smith AV, Taylor K, Scharpf RB, Hwang SJ, Sijbrands EJ, Bis J, Harris TB, Ganesh SK, O'Donnell CJ, Hofman A, Rotter JI, Coresh J, Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JC, Boerwinkle E, Wang TJ, Gudnason V, Larson MG, Chakravarti A, Psaty BM, van Duijn CM. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41:677-687.
11. Taal HR, Verwoert GC, Demirkan A, Janssens AC, Rice K, Ehret G, Smith AV, Verhaaren BF, Witteman JC, Hofman A, Vernooij MW, Uitterlinden AG, Rivadeneira F, Ikram MA, Levy D, van der Heijden AJ, Cohort for Heart and Aging Research in Genome Epidemiology and Early Genetics and Lifecourse Epidemiology Consortia, Jaddoe VW, van Duijn CM. Genome-wide profiling of blood pressure in adults and children. Hypertension 2012; 59:241-247.
12. Salvi E, Kutalik Z, Glorioso N, Benaglio P, Frau F, Kuznetsova T, Arima H, Hoggart C, Tichet J, Nikitin YP, Conti C, Seidlerova J, Tikhonoff V, Stolarz-Skrzypek K, Johnson T, Devos N, Zagato L, Guarrera S, Zaninello R, Calabria A, Stancanelli B, Troffa C, Thijs L, Rizzi F, Simonova G, Lupoli S, Argiolas G, Braga D, DAlessio MC, Ortu MF, Ricceri F, Mercurio M, Descombes P, Marconi M, Chalmers J, Harrap S, Filipovsky J, Bochud M, Iacoviello L, Ellis J, Stanton AV, Laan M, Padmanabhan S, Dominiczak AF, Samani NJ, Melander O, Jeunemaitre X, Manunta P, Shabo A, Vineis P, Cappuccio FP, Caulfield MJ, Matullo G, Rivolta C, Munroe PB, Barlassina C, Staessen JA, Beckmann JS, Cusi D. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension 2012; 59:248-255.
13. Hottenga JJ, Whitfield JB, Posthuma D, Willemsen G, de Geus EJ, Martin NG, Boomsma DI. Genome-wide scan for blood pressure in Australian and Dutch subjects suggests linkage at 5P, 14Q, and 17R Hypertension 2007; 49:832-838.
14. Hottenga JJ, Boomsma DI, Kupper N, Posthuma D, Snieder H, Willemsen G, de Geus EJ. Heritability and stability of resting blood pressure. Twin Res Hum Genet 2005; 8:499-508.
15. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 2003; 41:207-210.
16. Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, Burgess E, Lamarre-Cliché M, McLean D, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad GV, Lebel M, Campbell TS, Lindsay MP, Herman RJ, Larochelle P, Feldman RD, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Lewanczuk R, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Poirier L, Tobe SW; Canadian Hypertension Education Program. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011; 27:415-433.
17. Mancia G, Grassi G. Impact of new clinical trials on recent guidelines on hypertension management. Ann Med 2011; 43:124-132.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
19. Koopmans RP, Insel PA, Michel MC. Pharmacogenetics of hypertension treatment: a structured review. Pharmacogenetics 2003; 13:705-713.
20. Moser M. Black-white differences in response to antihypertensive medication. J Natl Med Assoc 1995; 87:612-613.
21. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis, J Hypertens 2004; 22:435-445.
22. Wu J, Kraja AT, Oberman A, Lewis CE, Ellison RC, Arnett DK, Heiss G, Lalouel JM, Turner ST, Hunt SC, Province MA, Rao DC. A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens 2005; 18:935-942.
23. Kraja AT, Huang P, Tang W Hunt SC, North KE, Lewis CE, Devereux RB, de Simone G, Arnett DK, Rice T, Rao DC. QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network study. BMC Med Genet 2008; 9:103.
24. Borghi C, Dormi A, DAddato S, Gaddi A, Ambrosioni E. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study, J Hypertens 2004; 22:1707-1716.
25. Stafford RS, Monti V Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension 2006; 48:213-218.
26. Ma J, Lee KV, Stafford RS. Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 2006; 48:846-852.
27. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55:399-407.
28. Byrd JB, Zeng C, Tavel HM, Magid DJ, O'Connor PJ, Margolis KL, Selby JV Ho PM. Combination therapy as initial treatment for newly diagnosed hypertension. Am Heart J 2011; 162:340-346.
29. Kremen WS, Jacobson KC, Xian H, Eisen SA, Waterman B, Toomey R, Neale MC, Tsuang MT, Lyons MJ. Heritability of word recognition in middle-aged men varies as a function of parental education. Behav Genet 2005; 35:417-433.
30. Wu T Snieder H, Li L, Cao W Zhan S, Lv J, Gao W Wang X, Ding X, Hu Y. Genetic and environmental influences on blood pressure and body mass index in Han Chinese: a twin study. Hypertens Res 2011; 34:173-179.
31. Evans DM, Gillespie NA, Martin NG. Biometrical genetics. Biol Psychol 2002;61:33-51.
32. Eisen S, True W Goldberg J, Henderson W Robinette CD. The Vietnam Era Twin (VET) Registry: method of construction. Acta Genet Med Gemellol (Roma) 1987; 36:61-66.
33. Henderson WG, Eisen S, Goldberg J, True WR, Barnes JE, Vitek ME. The Vietnam Era Twin Registry: a resource for medical research. Public Health Rep 1990; 105:368-373.
34. Centers for Disease Control and Prevention. Health Data Interactive http://www.cdc.gov/nchs/hdi.htm.
35. Panizzon MS, Lyons MJ, Jacobson KC, Franz CE, Grant MD, Eisen SA, Xian H, Kremen WS. Genetic architecture of learning and delayed recall: a twin study of episodic memory. Neuropsychology 2011; 25:488-498.
36. Glintborg B, Hillestrom PR, Olsen LH, Dalhoff KP, Poulsen HE. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients, J Clin Pharmacol 2007; 47:1440-1449.
37. Swift PA, MacGregor GA. The frequent need for three or more drugs to treat essential hypertension. What evidence for optimal combinations? I Renin Angiotensin Aldosterone Syst 2002; 3:103-108.
38. Volpe M, Christian Rump L, Ammentorp B, Laeis P. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodi-pine/ hydrochlorothiazide combination. Clin Drug Investig 2012; 32:649-664.
39. Ferdinand KC, Weitzman R, Israel M, Lee J, Purkayastha D, Jaimes EA. Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension, J Am Soc Hypertens 2011; 5:102-113.
40. Murray AV, Koenig W Garcia-Puig J, Patel S, Uddin A, Zhang J. Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label study, J Clin Hypertens (Greenwich) 2012; 14:821-827.
41. Huan Y Townsend R. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension. Expert Opin Pharmacother 2012; 13:2409-2415.
42. Laffer CL, Elijovich F. A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals. Integr Blood Press Control 2011; 4:1-5.
43. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Development Core Team, nlme: Linear and Nonlinear Mixed Effects Models. R package, 2012.
44. Cohen J, Cohen P. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. Halsted Press: New York, 1975.
45. Neale MC, Boker SM, Xie G, Maes HH. Mx: Statistical Modeling. 6th edn. Department of Psychiatry, Medical College of Virginia: Richmond, 2004.
46. Neale MC, Cardon L.R. Methodology for Genetic Studies of Twins and Families. Kluwer Academic Publishers: Dordrecht, the Netherlands, 1992.
47. Carey G. Inference about genetic correlations. Behav Genet 1988; 18:329-338.
48. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004; 44:398-404.
49. Cutler JA, Sorlie PD, Wolz M, Thorn T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52:818-827.
50. Ehret GB, Morrison AC, O'Connor AA, Grove ML, Baird L, Schwander K, Weder A, Cooper RS, Rao DC, Hunt SC, Boerwinkle E, Chakravarti A. Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur I Hum Genet 2008; 16:1507-1511.
51. Kocemba J, Kawecka-Jaszcz K, Gryglewska B, Grodzicki T Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits, J Hum Hypertens 1998; 12:621-626.
52. Black HR. Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions, J Hypertens 1999; 17:S49-54.
53. Franz CE, Grant MD, Jacobson KC, Kremen WS, Eisen SA, Xian H, Romeis J, Thompson-Brenner H, Lyons MJ. Genetics of body mass stability and risk for chronic disease: a 28-year longitudinal study. Twin Res Hum Genet 2007; 10:537-545.
54. Dudina A, Cooney MT, Bacquer DD, Backer GD, Ducimetière P, Jousilahti P, Keil U, Menotti A, Njolstad I, Oganov R, Sans S, Thomsen T, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Conroy R, Fitzgerald A, Graham I, SCORE investigators. Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil 2011; 18:731-742.